CN101506168B - 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 - Google Patents
具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 Download PDFInfo
- Publication number
- CN101506168B CN101506168B CN200680055744.7A CN200680055744A CN101506168B CN 101506168 B CN101506168 B CN 101506168B CN 200680055744 A CN200680055744 A CN 200680055744A CN 101506168 B CN101506168 B CN 101506168B
- Authority
- CN
- China
- Prior art keywords
- carbon atom
- acid
- structural formula
- represent
- compound
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 0 CCC(C)(*)CC(C)(CC)N(*)* Chemical compound CCC(C)(*)CC(C)(CC)N(*)* 0.000 description 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/79—Acids; Esters
- C07D213/80—Acids; Esters in position 3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C327/00—Thiocarboxylic acids
- C07C327/20—Esters of monothiocarboxylic acids
- C07C327/30—Esters of monothiocarboxylic acids having sulfur atoms of esterified thiocarboxyl groups bound to carbon atoms of hydrocarbon radicals substituted by nitrogen atoms, not being part of nitro or nitroso groups
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pain & Pain Management (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pyridine Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
组别 | 剂量(mg/kg) | 扭体次数 | 抑制率(%) |
A | 0 | 35.0 | - |
B | 100 | 15.6 | 55 |
C | 100 | 14.2 | 59 |
D | 100 | 16.1 | 54 |
E | 100 | 15.2 | 57 |
F | 100 | 15.7 | 55 |
化合物 | t=0min. | t=90min. | t=180min. | t=270min. |
A(对照组) | 37.34±0.05 | 37.36±0.07 | 37.37±0.05 | 37.44±0.08 |
B(100mg/kg) | 37.35±0.06 | 36.71±0.05 | 36.60±0.08 | 36.59±0.07 |
C(100mg/kg) | 37.28±0.06 | 36.68±0.05 | 36.62±0.08 | 36.58±0.07 |
D(100mg/kg) | 37.27±0.06 | 36.76±0.05 | 36.65±0.08 | 36.49±0.07 |
E(100mg/kg) | 37.25±0.07 | 36.82±0.06 | 36.70±0.05 | 36.50±0.08 |
F(100mg/kg) | 37.23±0.06 | 36.69±0.06 | 36.52±0.08 | 36.40±0.07 |
Claims (43)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510019131.9A CN104706630B (zh) | 2006-09-03 | 2006-09-03 | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/IB2006/053090 WO2008029199A1 (en) | 2006-09-03 | 2006-09-03 | Positively charged water-soluble prodrugs of n-arylanthranilic acids with very fast skin penetration rate |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510019131.9A Division CN104706630B (zh) | 2006-09-03 | 2006-09-03 | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101506168A CN101506168A (zh) | 2009-08-12 |
CN101506168B true CN101506168B (zh) | 2014-12-10 |
Family
ID=39156867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200680055744.7A Active CN101506168B (zh) | 2006-09-03 | 2006-09-03 | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 |
Country Status (6)
Country | Link |
---|---|
EP (2) | EP2084132B1 (zh) |
CN (1) | CN101506168B (zh) |
ES (2) | ES2694685T3 (zh) |
HK (1) | HK1137426A1 (zh) |
PL (2) | PL2623495T3 (zh) |
WO (1) | WO2008029199A1 (zh) |
Families Citing this family (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7632866B2 (en) | 2002-10-21 | 2009-12-15 | Ramot At Tel Aviv University | Derivatives of N-phenylanthranilic acid and 2-benzimidazolone as potassium channel and/or neuron activity modulators |
US20090221703A1 (en) | 2006-07-09 | 2009-09-03 | Chongxi Yu | High penetration composition and uses thereof |
US20090238763A1 (en) | 2006-07-09 | 2009-09-24 | Chongxi Yu | High penetration compositions and uses thereof |
WO2008041054A1 (en) | 2006-10-02 | 2008-04-10 | Techfields Biochem Co. Ltd | Positively charged water-soluble prodrugs of prostaglandins and related compounds with very high skin penetration rates |
AU2006350707A1 (en) | 2006-11-08 | 2008-05-15 | Chongxi Yu | Transdermal delivery systems of peptides and related compounds |
EP2656879B1 (en) | 2006-12-10 | 2017-06-28 | Chongxi Yu | Transdermal delivery systems of beta-lactam antibiotics |
CA2674822C (en) | 2007-01-15 | 2017-08-01 | Chongxi Yu | Positively charged water-soluble prodrugs of retinoids and retinoid-like compounds with very high skin penetration rates |
ES2607901T3 (es) | 2007-01-31 | 2017-04-04 | Chongxi Yu | Profármacos hidrosolubles cargados positivamente de 1H-imidazo[4,5-c]quinolin-4-aminas y compuestos relacionados con ratas de penetración de piel muy altas |
PL2170826T3 (pl) * | 2007-06-04 | 2022-09-05 | Techfields Inc | Proleki nsaia o bardzo wysokim współczynniku przenikania przez skórę i błony oraz ich nowe zastosowania lecznicze |
WO2009037705A2 (en) * | 2007-09-20 | 2009-03-26 | Ramot At Tel Aviv University Ltd. | Esters of n-phenylanthranilic acid for use in the treatment of cancer and inflammation |
CN101868443A (zh) | 2007-09-20 | 2010-10-20 | 特拉维夫大学拉莫特有限公司 | N-苯基邻氨基苯甲酸衍生物及其用途 |
CA3213470A1 (en) | 2008-12-04 | 2010-06-10 | Chongxi Yu | High penetration compositions and their applications |
DK2427475T3 (da) | 2009-05-08 | 2021-02-01 | Techfields Biochem Co Ltd | Prodrug-sammensætninger med høj gennemtrængelighed af peptider og peptid-relaterede forbindelser |
US9969751B2 (en) | 2009-06-10 | 2018-05-15 | Techfields Pharma Co., Ltd. | High penetration prodrug compositions of antimicrobials and antimicrobial-related compounds |
US20120022116A1 (en) * | 2010-07-20 | 2012-01-26 | Huayun Deng | Compositions and methods for the treatment of pathological condition(s) related to gpr35 and/or gpr35-herg complex |
CA3189252A1 (en) * | 2012-05-16 | 2013-11-21 | Techfields Pharma Co., Ltd. | High penetration prodrug compositions and pharmaceutical composition thereof for treatment of pulmonary conditions |
WO2014139161A1 (en) | 2013-03-15 | 2014-09-18 | Techfields Pharma Co., Ltd. | Novel high penetration drugs and their compositions thereof for treatment of parkinson diseases |
US20160168108A1 (en) | 2014-12-16 | 2016-06-16 | Adt Pharmaceuticals, Inc. | Method of treating or preventing ras-mediated diseases |
US9862698B2 (en) | 2014-12-16 | 2018-01-09 | Adt Pharmaceuticals, Inc. | Indenyl compounds, pharmaceutical compositions, and medical uses thereof |
JP7169008B2 (ja) | 2018-04-26 | 2022-11-10 | エーディーティー ファーマシューティカルズ,エルエルシー | 抗がんインデン、インダン、アザインデン、アザインダン、医薬組成物および使用 |
WO2020070557A1 (en) * | 2018-10-02 | 2020-04-09 | Q Biomed Inc. | Modified therapeutic agent analogs of mefenamic acid |
EP4021449A4 (en) * | 2019-08-30 | 2023-11-01 | University of South Florida | STITCH MODULATORS, COMPOSITIONS AND METHODS OF USE |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB100208A (en) * | 1915-03-24 | 1917-03-01 | Isidore Swientoslawsk Morrison | Improvements in Watch Movements. |
GB984471A (en) * | 1961-01-12 | 1965-02-24 | Parke Davis & Co | Anthranilic acid esters and methods for producing the same |
US3420871A (en) * | 1964-09-01 | 1969-01-07 | Parke Davis & Co | Anthranilic acid esters |
GB1187259A (en) * | 1967-10-23 | 1970-04-08 | Hexachimie | New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2671805A (en) * | 1952-07-02 | 1954-03-09 | Searle & Co | Basically substituted o-arylamino-benzamides |
BE630053A (zh) * | 1962-03-27 | |||
DK121236B (da) * | 1967-07-03 | 1971-09-27 | Gea As | Analogifremgangsmåde til fremstilling af terapeutisk aktive, basisk substituerede amider af N-substituerede antranilsyrer, eller syreadditionssalte deraf. |
US3814811A (en) * | 1972-06-07 | 1974-06-04 | Andreu Sa Dr | Method of eliminating or alleviating local pain with diethylaminoethyl flufenamate |
JPS57183738A (en) * | 1981-05-06 | 1982-11-12 | Yamanouchi Pharmaceut Co Ltd | Aromatic carboxylic acid derivative |
ZA882957B (en) * | 1987-04-27 | 1989-12-27 | Syntex Pharma Int | Omega-quaternary ammonium alkyl esters and thioesters of acidic nonsteroidal anti-inflammatory drugs |
US5654337A (en) | 1995-03-24 | 1997-08-05 | II William Scott Snyder | Topical formulation for local delivery of a pharmaceutically active agent |
AUPN531195A0 (en) | 1995-09-11 | 1995-10-05 | J.W. Broadbent Nominees Pty. Ltd. | Lipid extract having anti-inflamatory activity |
KR100213465B1 (ko) | 1996-11-01 | 1999-08-02 | 최좌진 | 케토프로펜 패취 조성물 |
US5885597A (en) | 1997-10-01 | 1999-03-23 | Medical Research Industries,Inc. | Topical composition for the relief of pain |
AU4972599A (en) | 1998-07-07 | 2000-01-24 | Transdermal Technologies, Inc. | Compositions for rapid and non-irritating transdermal delivery of pharmaceutically active agents and methods for formulating such compositions and delivery thereof |
US6416772B1 (en) | 2001-01-12 | 2002-07-09 | H. Wayne Van Engelen | Topical dermal anaesthetic |
US6528040B1 (en) | 2001-01-18 | 2003-03-04 | Maurine Pearson | EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic |
US7052715B2 (en) | 2003-04-11 | 2006-05-30 | All Natural Fmg, Inc. | Alcohol-free transdermal analgesic composition and processes for manufacture and use thereof |
-
2006
- 2006-09-03 EP EP06795893.4A patent/EP2084132B1/en not_active Not-in-force
- 2006-09-03 EP EP13153470.3A patent/EP2623495B1/en active Active
- 2006-09-03 ES ES06795893.4T patent/ES2694685T3/es active Active
- 2006-09-03 PL PL13153470T patent/PL2623495T3/pl unknown
- 2006-09-03 PL PL06795893T patent/PL2084132T3/pl unknown
- 2006-09-03 CN CN200680055744.7A patent/CN101506168B/zh active Active
- 2006-09-03 WO PCT/IB2006/053090 patent/WO2008029199A1/en active Application Filing
- 2006-09-03 ES ES13153470T patent/ES2735287T3/es active Active
-
2010
- 2010-01-28 HK HK10100929.4A patent/HK1137426A1/zh unknown
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB100208A (en) * | 1915-03-24 | 1917-03-01 | Isidore Swientoslawsk Morrison | Improvements in Watch Movements. |
GB984471A (en) * | 1961-01-12 | 1965-02-24 | Parke Davis & Co | Anthranilic acid esters and methods for producing the same |
US3420871A (en) * | 1964-09-01 | 1969-01-07 | Parke Davis & Co | Anthranilic acid esters |
GB1187259A (en) * | 1967-10-23 | 1970-04-08 | Hexachimie | New Aminoalkyl Esters of 2-Anilino-Nicotinic Acids and process for their manufacture |
Non-Patent Citations (1)
Title |
---|
JP昭57-183738A 1982.11.12 * |
Also Published As
Publication number | Publication date |
---|---|
EP2623495B1 (en) | 2019-05-01 |
PL2623495T3 (pl) | 2019-11-29 |
EP2084132A4 (en) | 2010-05-26 |
EP2623495A1 (en) | 2013-08-07 |
CN101506168A (zh) | 2009-08-12 |
WO2008029199A1 (en) | 2008-03-13 |
EP2084132A1 (en) | 2009-08-05 |
ES2694685T3 (es) | 2018-12-26 |
PL2084132T3 (pl) | 2019-03-29 |
EP2084132B1 (en) | 2018-08-08 |
HK1137426A1 (zh) | 2010-07-30 |
ES2735287T3 (es) | 2019-12-17 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101506168B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 | |
CN101506161B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基和杂芳基丙酸类前药 | |
CN101489985B (zh) | 具有快速皮肤穿透率的带正电荷的水溶性布洛芬前药 | |
CN101500983B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性二氟尼柳及相关化合物的前药 | |
JP5466006B2 (ja) | 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ | |
JP5542436B2 (ja) | 非常に速い皮膚透過率を有するジクロフェナクの正荷電水溶性プロドラッグ | |
EP2990402A1 (en) | Positively charged water-soluble prodrugs of aryl- and heteroarylacetic acids with very fast skin penetration rate | |
CN108250090B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药 | |
AU2013231152B2 (en) | Positively charged water-soluble pro-drugs of ibuprofen | |
CN104622858B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药 | |
CN104610077B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性酮洛芬及相关化合物的前药 | |
JP5855599B2 (ja) | 非常に速い皮膚浸透率を有するアセトアミノフェン及び関連化合物の正荷電水溶性プロドラッグ | |
CN104706630B (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基邻氨基苯甲酸的前药 | |
CN103351308A (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性的对乙酰氨基酚及其相关化合物的前药 | |
CN103772258B (zh) | 具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药 | |
CN103705496A (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性的芳基和杂芳基丙酸类前药 | |
CN103772259B (zh) | 具有快速皮肤穿透速度的带正电荷的芳基和杂芳基乙酸类前药 | |
CN104974058A (zh) | 具有快速皮肤穿透速度的带正电荷的水溶性双氯芬酸前药 | |
CN105439877B (zh) | 带正电荷的水溶性二氟尼柳及相关化合物的前药 | |
CN103948571A (zh) | 具有快速皮肤穿透率的带正电荷的水溶性布洛芬前药 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1137426 Country of ref document: HK |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1137426 Country of ref document: HK |
|
CP01 | Change in the name or title of a patent holder | ||
CP01 | Change in the name or title of a patent holder |
Address after: Illinois, America Patentee after: Yu Chongxi Patentee after: Taifeier biomedical (Suzhou) Co.,Ltd. Address before: Illinois, America Patentee before: Yu Chongxi Patentee before: Shanghai Taifeier Biochemical Technology Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20220520 Address after: 215129 Room 401, building 9, No. 168, Majian Road, high tech Zone, Suzhou, Jiangsu Province Patentee after: Taifeier biomedical (Suzhou) Co.,Ltd. Address before: Illinois, America Patentee before: Yu Chongxi Patentee before: Taifeier biomedical (Suzhou) Co.,Ltd. |